NCT02523404View on ClinicalTrials.gov

HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA）for Lung Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Lung Cancer
Interventions
PROCEDURE

interventional therapy

lung cancer patients received HepaSphere interventional therapy using the digital subtraction angiography（DSA）

Trial Locations (1)

510000

Central laboratory in Fuda cancer hospital, Guangzhou

All Listed Sponsors
lead

Fuda Cancer Hospital, Guangzhou

OTHER

NCT02523404 - HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA）for Lung Cancer | Biotech Hunter | Biotech Hunter